Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

CONCLUSIONS: Overall, this study serves as the first to delineate toxicity profiles associated with various available CAR T products. By better understanding associated toxicities, it may become possible to tailor therapies towards individual patients and anticipate the development of toxicities at earlier stages.PMID:38582666 | DOI:10.1016/j.clml.2024.02.007

Source: Clinical Lymphoma and Myeloma - April 6, 2024 Category: Cancer & Oncology Authors: Samuel Yamshon Caitlin Gribbin Mohammad Alhomoud Nora Chokr Zhengming Chen Michelle Demetres Michelle Pasciolla John Leonard Tsiporah Shore Peter Martin Source Type: research